Swedish study links full-fat cheese and cream to lower dementia risk

A 25-year Swedish study of nearly 28,000 people, published in Neurology, found that higher daily intake of full-fat cheese and cream was associated with a 13% to 24% lower risk of dementia—particularly in those without genetic predispositions—but not for low-fat dairy or those with genetic risks. The findings challenge low-fat dairy recommendations and emphasize overall healthy diets.

Researchers from Lund University, including Yufeng Du and Emily Sonestedt, followed 27,670 middle-aged and older adults (average age 58 at baseline) for 25 years. During this period, 3,208 developed dementia. Food intake was assessed via weekly logs and frequency questionnaires.

Among participants without the APOE e4 genetic risk for Alzheimer’s, consuming more than 50 grams of full-fat cheese daily (e.g., cheddar, Brie, Gouda; >20% fat, about two slices) was linked to a 13% to 17% lower Alzheimer’s risk and reduced overall dementia rates (10% vs. 13% in low-intake group). Over 20 grams of full-fat cream daily (30-40% fat, ~1.4 tablespoons) correlated with a 16% to 24% lower dementia risk, strongest for vascular dementia (29% reduction). No associations were seen for low-fat cheese/cream, milk (fermented or not), butter, or yogurt, nor in genetically at-risk individuals.

"For decades, the debate over high-fat versus low-fat diets has shaped health advice, sometimes even categorizing cheese as an unhealthy food to limit," said lead researcher Emily Sonestedt, PhD. "Our study found that some high-fat dairy products may actually lower the risk of dementia, challenging some long-held assumptions about fat and brain health. These findings suggest that when it comes to brain health, not all dairy is equal."

The study (Neurology, 2026;106(2)), funded by Swedish organizations like the Swedish Research Council, excluded early dementia cases and adjusted for age, sex, education, diet quality, and lifestyle to minimize biases. Higher cheese/cream consumers were often more educated, slimmer, and healthier overall.

Results contrast with low-fat dairy advice for heart health, given overlaps with dementia risks (hypertension, diabetes, obesity). Prior evidence is mixed: a Finnish study of 2,497 men (22 years) linked cheese to 28% lower dementia risk; Japanese research found none. Asian studies note benefits at low dairy intakes; European ones vary.

Full-fat cheese offers brain nutrients like vitamins A, D, K2, B12, folate, iodine, zinc, and selenium. Researchers stress no single food prevents dementia—balanced patterns like the Mediterranean diet (moderate cheese with fish, fruits, vegetables, grains) are key. Benefits may stem from substitutions (e.g., dairy over processed meats), absent in stable diets. Limitations include Swedish population (uncooked cheese common), self-reported diets, and observational design showing association, not causation. Further research across populations is needed.

Verwandte Artikel

Illustration of scientists analyzing genetic data linking lower cholesterol to reduced dementia risk in a lab setting.
Bild generiert von KI

Genetic study links lower cholesterol to reduced dementia risk

Von KI berichtet Bild generiert von KI Fakten geprüft

A large-scale genetic analysis of about 1.09 million people suggests that lifelong, genetically lower cholesterol—specifically non‑HDL cholesterol—is associated with substantially reduced dementia risk. Using Mendelian randomization to emulate the effects of cholesterol‑lowering drug targets such as those for statins (HMGCR) and ezetimibe (NPC1L1), the study found up to an approximately 80% lower risk per 1 mmol/L reduction for some targets. ([research-information.bris.ac.uk](https://research-information.bris.ac.uk/en/publications/cholesterollowering-drug-targets-reduce-risk-of-dementia-mendelia?utm_source=openai))

A Swedish study suggests that consuming more high-fat cheese could lower dementia risk by 13%, based on data from nearly 30,000 people followed for 25 years. However, experts caution that it is an observational analysis without proof of causality. Critics highlight potential confounders and the importance of factors like blood pressure and weight control.

Von KI berichtet

A new genetic study indicates that obesity and high blood pressure directly contribute to dementia, beyond merely raising its risk. Researchers from Denmark and the U.K. used advanced methods to establish this causal link, emphasizing prevention through weight and blood pressure management. The findings suggest early interventions could avert vascular-related dementia.

Eine kürzlich anerkannte Form der Demenz, bekannt als LATE, verändert das Verständnis des kognitiven Abbaus bei Älteren, mit steigenden Diagnosen und Leitlinien für Ärzte, die in diesem Jahr veröffentlicht wurden. Sie betrifft schätzungsweise etwa ein Drittel der Menschen ab 85 Jahren und 10 % der ab 65 Jahren, oft verwechselt mit Alzheimer. Experten betonen die Notwendigkeit eines breiteren Spektrums an Behandlungen für diese Erkrankung.

Von KI berichtet Fakten geprüft

An analysis of more than 63,000 French adults from the long-running NutriNet-Santé cohort found that plant-based diets built around minimally processed, nutritionally high-quality foods were associated with about a 40% lower risk of cardiovascular disease, while diets heavy in ultra-processed plant products could erase this benefit and were tied to substantially higher risk, according to researchers from INRAE and partner institutions.

An analysis of health records from Wales found that older adults who received a shingles vaccine were about 20% less likely to be diagnosed with dementia over seven years than their unvaccinated peers. The research, which took advantage of an age-based rollout of the vaccine as a natural experiment, also suggests potential benefits for people already living with dementia and indicates stronger effects in women.

Von KI berichtet Fakten geprüft

Researchers at Kindai University report that oral arginine, a common amino acid, suppresses amyloid‑β aggregation and its toxic effects in fruit fly and mouse models of Alzheimer’s disease. In treated animals, amyloid buildup fell, inflammation markers dropped, and behavioral performance improved, suggesting arginine could be a low‑cost candidate for drug repurposing.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen